Better communication is needed about the flow of drugs, from the manufacturer, through the distribution network to the hospital and, at the end, how those medications are being prescribed.

Invisible Threats gives supply chain professionals guidance on identifying risk hotspots right now based on data analysis of private and public companies’ financial health, by NAISC.

VR holds immense potential to transform supply chain management, driving innovation and efficiency.

The U.S. can’t have a vibrant “bio-based” manufacturing sector without an equally strong source of domestic materials to support it.

The convergence of technology and legislation offers a multi-faceted approach to combating organized retail crime.

Are you evaluating your next warehouse facility or considering lease renewal? JLL's warehouse lease renewal checklist provides a comprehensive guide to simplify your decision-making process.

Product lead time is crucial in the life sciences industry and represents a key consideration for customers’ purchasing decisions. For this reason, BD Biosciences aimed to optimize its global supply and distribution network to reduce delivery lead time to customers and optimize its global inventory. 

The smart parcel locker market is experiencing rapid growth amid increasing demand for efficient and secure package delivery solutions.

Drug shortages in the U.S. have reached an all-time high. A total of 323 shortages were reported during the first quarter of 2024, suggesting that previous strategies had failed to reverse the trend.

Time is running out for the healthcare supply chain to fully comply with the Drug Supply Chain Security Act.